Literature DB >> 17228366

The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients.

J S Gill1, C Rose, B J G Pereira, M Tonelli.   

Abstract

Analyses describing outcomes of kidney transplantation usually exclude the survival of wait-listed patients and dialysis patients with failed kidney transplants, and thus reflect only a portion of the typical transplant process. We determined death rates during the continuum of wait-listing, transplantation, and after allograft failure among adult end-stage renal disease patients in the United States between 1995 and 2003. Before transplantation, death rates increased with longer waiting times. Death rates were lowest during the period of allograft function and highest after allograft failure. Patients were at particularly high risk during periods of transition between dialysis and transplantation (death rates during the peri-transplant period and during the re-initiation of dialysis after transplant failure were 8.2/100 patient-years (95% confidence interval (CI) 7.7, 8.8) and 17.9/100 patient-years (95% CI 15.7, 20.3), respectively compared to 6.4/100 patient-years (95% CI 6.25, 6.51) during the period of wait-listing. Diabetic patients and older patients were at increased risk at all time points. The most common known cause of death in all age subgroups was cardiovascular disease. The proportion of death owing to sepsis was greatest after allograft failure (16.8% of all deaths were due to sepsis compared to 14.0% during wait-listing, and 12.7% during the period of allograft function). Consideration of the entire transplant experience as a whole should help to focus patient care on periods of particularly high risk, and emphasizes opportunities to improve outcomes by strategies aimed at preventing death owing to cardiovascular and infectious causes.

Entities:  

Mesh:

Year:  2007        PMID: 17228366     DOI: 10.1038/sj.ki.5002072

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

Authors:  M Z Molnar; E Streja; C P Kovesdy; S Bunnapradist; M S Sampaio; J Jing; M Krishnan; A R Nissenson; G M Danovitch; K Kalantar-Zadeh
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

2.  Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States.

Authors:  Rajnish Mehrotra; Kenneth Story; Steven Guest; Michelle Fedunyszyn
Journal:  Perit Dial Int       Date:  2011-12-01       Impact factor: 1.756

3.  Efficacy and Safety of Intra-gastric Balloon Placement in Dialyzed Patients Awaiting Kidney Transplantation.

Authors:  Séverine Beaudreuil; Franck Iglicki; Séverine Ledoux; Michelle Elias; Erika NNang Obada; Hadia Hebibi; Emmanuel Durand; Bernard Charpentier; Benoit Coffin; Antoine Durrbach
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

4.  Transplant nephrectomy after graft failure: is it so risky? Impact on morbidity, mortality and alloimmunization.

Authors:  Y Chowaniec; F Luyckx; G Karam; P Glemain; J Dantal; J Rigaud; J Branchereau
Journal:  Int Urol Nephrol       Date:  2018-08-17       Impact factor: 2.370

5.  Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival: An Analysis of National Data to Inform Allocation Policy.

Authors:  Stephanie Clark; Matthew Kadatz; Jagbir Gill; John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-23       Impact factor: 8.237

6.  Hemodialysis Quality Metrics in the First Year Following a Failed Kidney Transplant.

Authors:  Anne M Huml; Ashwini R Sehgal
Journal:  Am J Nephrol       Date:  2019-07-16       Impact factor: 3.754

7.  Selective retransplant after graft loss to nonadherence: success with a second chance.

Authors:  T B Dunn; B J Browne; K J Gillingham; R Kandaswamy; A Humar; W D Payne; D E R Sutherland; A J Matas
Journal:  Am J Transplant       Date:  2009-05-13       Impact factor: 8.086

Review 8.  Cardiovascular disease in transplant recipients: current and future treatment strategies.

Authors:  John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

9.  The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.

Authors:  Christine M Durand; Mary G Bowring; Alvin G Thomas; Lauren M Kucirka; Allan B Massie; Andrew Cameron; Niraj M Desai; Mark Sulkowski; Dorry L Segev
Journal:  Ann Intern Med       Date:  2018-04-17       Impact factor: 25.391

10.  Urotensin II levels in patients with chronic kidney disease and kidney transplants.

Authors:  Mehmet Hursitoglu; Tufan Tukek; Mehmet Ali Cikrikcioglu; Osman Kara; Rumeyza Kazancioglu; Oktay Ozkan; Mustafa Cakirca; Fatih Akdogan; Erdal Gundogan; Sengul Aydin; Ismet Beycan; Meltem Gursu; Serkan Dogan; Aybala Erek
Journal:  Ups J Med Sci       Date:  2011-11-18       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.